The introduction of biosimilars will increase pricing pressure and challenge the market share of originator brands
GLP-1 Receptor Agonists -Cell Function The anti-hyperglycemic benefits attributable to GLP-1RA-based therapy are primarily due to their direct action on pancreatic -cells
Wegovy and Zepbound are injected once weekly, while Saxenda is injected once daily, making it a bit less convenient
This creates a specific treatment duration consideration for patients of reproductive age
Other neuroprotective mechanisms potentially involved in the treatment of cognitive disorders as well as cerebrovascular disease and epilepsy suggest that GLP-1RAs can enhance the viability of neurons and restore neurite outgrowth by stimulating neurotrophic factors, thus increasing subventricular zone progenitor cells, decreasing apoptosis and the level of pro-inflammatory factors, and strengthening the bloodbrain barrier 37
By distribution channel, the drug stores & retail pharmacies segment accounted for a share of 44.68% in 2025